Emenda Therapeutics is a biotech company developing small molecule kinase inhibitors to control alternative RNA splicing. We aim to treat a variety of diseases, including osteoathritis, chronic pain and cancer.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Address:
16 NEXUS WAY; SOUTHPORT, QUEENSLAND 4215, AU
LOW
spending power